Effects of the α2-adrenoceptor agonist medetomidine on the distribution and clearance of alfaxalone during coadministration by constant rate infusion in dogs-Reference-Cited by-同舟云学术

Effects of the α2-adrenoceptor agonist medetomidine on the distribution and clearance of alfaxalone during coadministration by constant rate infusion in dogs

Published:2017-08 Issue:8 Volume:78 Page:956-964
ISSN:0002-9645
Container-title:American Journal of Veterinary Research
language:en
Short-container-title:American Journal of Veterinary Research

Author:

Bennett Rachel C.,Salla Kati M.,Raekallio Marja R.,Scheinin Mika,Vainio Outi M.

Publisher

American Veterinary Medical Association (AVMA)

Subject

General Veterinary,General Medicine

Reference42 articles.

1. Modification of GABA-mediated Inhibition by Various Injectable Anesthetics

2. Preemptive Analgesic Effects of Steroid Anesthesia with Alphaxalone in the Rat Formalin Test

3. THE PHARMACOLOGICAL PROPERTIES IN ANIMALS OF CT1341—A NEW STEROID ANAESTHETIC AGENT

4. Complications of saffan anaesthesia in cats

5. Plasma pharmacokinetics of alfaxalone in dogs after an intravenous bolus of Alfaxan-CD RTU

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of vatinoxan in dogs premedicated with medetomidine and butorphanol followed by sevoflurane anaesthesia: a randomized clinical study;Veterinary Anaesthesia and Analgesia;2022-11

2. Effects of sevoflurane, propofol or alfaxalone on neuromuscular blockade produced by a single intravenous bolus of rocuronium in dogs;Veterinary Anaesthesia and Analgesia;2022-01

3. Clinical review of the pharmacological and anaesthetic effects of alfaxalone in dogs;Journal of Small Animal Practice;2021-12-10

4. Vatinoxan – a new development for the clinical use of α2-adrenoceptor agonists in dogs: part 2;Companion Animal;2021-11-02

5. Perioperative pharmacokinetics and pharmacodynamics of meloxicam in emus ( Dromaius novaehollandiae) of different age groups using nonlinear mixed effect modelling;Journal of Veterinary Pharmacology and Therapeutics;2020-11-03